| ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion V Cesarini, DA Silvestris, V Tassinari, S Tomaselli, S Alon, E Eisenberg, ... Nucleic acids research 46 (4), 2045-2059, 2018 | 105 | 2018 |
| The interplay between CD27dull and CD27bright B cells ensures the flexibility, stability, and resilience of human B cell memory O Grimsholm, EP Mortari, AN Davydov, M Shugay, AS Obraztsova, ... Cell reports 30 (9), 2963-2977. e6, 2020 | 82 | 2020 |
| ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism V Tassinari, V Cesarini, S Tomaselli, Z Ianniello, DA Silvestris, ... Genome biology 22, 1-22, 2021 | 80 | 2021 |
| Increased adenosine-to-inosine RNA editing in rheumatoid arthritis NI Vlachogiannis, A Gatsiou, DA Silvestris, K Stamatelopoulos, ... Journal of autoimmunity 106, 102329, 2020 | 57 | 2020 |
| Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma DA Silvestris, E Picardi, V Cesarini, B Fosso, N Mangraviti, L Massimi, ... Genome biology 20, 1-18, 2019 | 51 | 2019 |
| ADAR-mediated RNA editing of DNA: RNA hybrids is required for DNA double strand break repair S Jimeno, R Prados-Carvajal, MJ Fernández-Ávila, S Silva, DA Silvestris, ... Nature communications 12 (1), 5512, 2021 | 39 | 2021 |
| Safe and effective off-the-shelf immunotherapy based on CAR. CD123-NK cells for the treatment of acute myeloid leukaemia S Caruso, B De Angelis, F Del Bufalo, R Ciccone, S Donsante, G Volpe, ... Journal of Hematology & Oncology 15 (1), 163, 2022 | 32 | 2022 |
| Quantifying RNA editing in deep transcriptome datasets C Lo Giudice, DA Silvestris, SH Roth, E Eisenberg, G Pesole, A Gallo, ... Frontiers in Genetics 11, 194, 2020 | 30 | 2020 |
| The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer V Tassinari, V Cesarini, DA Silvestris, A Gallo Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1862 (3), 291-300, 2019 | 19 | 2019 |
| Aptamer-based in vivo therapeutic targeting of glioblastoma V Cesarini, C Scopa, DA Silvestris, A Scafidi, V Petrera, G Del Baldo, ... Molecules 25 (18), 4267, 2020 | 18 | 2020 |
| De novo A-to-I RNA editing discovery in lncRNA DA Silvestris, C Scopa, S Hanchi, F Locatelli, A Gallo Cancers 12 (10), 2959, 2020 | 13 | 2020 |
| SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity M Rosichini, V Bordoni, DA Silvestris, D Mariotti, G Matusali, A Cardinale, ... Journal of Allergy and Clinical Immunology 151 (4), 911-921, 2023 | 10 | 2023 |
| Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies S Manni, F Del Bufalo, P Merli, DA Silvestris, M Guercio, S Caruso, ... Nature Communications 14 (1), 3423, 2023 | 9 | 2023 |
| Quantifying RNA editing in deep transcriptome datasets. Front. Genet. 11, 194 C Lo Giudice, DA Silvestris, SH Roth, E Eisenberg, G Pesole, A Gallo, ... | 6 | 2020 |
| The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation A Gatsiou, S Tual-Chalot, M Napoli, A Ortega-Gomez, T Regen, R Badolia, ... Immunity 56 (5), 979-997. e11, 2023 | 5 | 2023 |
| MicroRNA editing detection and function: A combined in silico and experimental approach for the identification and validation of putative oncogenic targets V Tassinari, V Cesarini, DA Silvestris, A Scafidi, L Cucina, A Gallo RNA Editing: Methods and Protocols, 253-267, 2021 | 4 | 2021 |
| Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors E Lazzarini, DA Silvestris, G Benvenuto, D Osti, L Fattore, R Paterra, ... Journal of Neuro-oncology 163 (1), 47-59, 2023 | 3 | 2023 |
| ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature V Cesarini, DA Silvestris, F Galeano, V Tassinari, M Martini, F Locatelli, ... Biomolecules 12 (8), 1142, 2022 | 2 | 2022 |
| dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells M Centrone, M D’Agostino, M Ranieri, MG Mola, P Faviana, PV Lippolis, ... Frontiers in Cell and Developmental Biology 10, 919438, 2022 | 2 | 2022 |
| Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy ML Carbone, A Capone, M Guercio, S Reddel, DA Silvestris, D Lulli, ... Frontiers in Immunology 14, 1197630, 2023 | 1 | 2023 |
